Press Releases

SAN FRANCISCO and SUZHOU, China, May 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and other major diseases, today announced that the New Drug Application (NDA) for IBI311, a recombinant anti-insulin-like growth factor 1 receptor (IGF-1R) antibody, has been... (continue reading...)

• SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira®

REYKJAVIK, Iceland and PARSIPPANY, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO), today announced the availability of SIMLANDI (adalimumab-ryvk) injection in the U.S., as an interchangeable biosimilar to Humira for the treatment of adult rheumatoid... (continue reading...)

• SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira®

REYKJAVIK, ICELAND & PARSIPPANY, NJ  — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO), today announced the availability of SIMLANDI (adalimumab-ryvk) injection in the U.S., as an interchangeable biosimilar to Humira for the treatment of adult rheumatoid arthritis, juvenile idiopathic arthritis,... (continue reading...)

White House issues new fact sheet highlighting the need for more equitable access to school transportation as key solution to absenteeism crisis

LOS ANGELES--(BUSINESS WIRE)-- HopSkipDrive, a technology company that solves complex transportation challenges where there is a heightened need for safety, equity and care, commends the White House for the new actions and resources it announced at its Every Day Counts Summit to curb chronic absenteeism.

Ahead of the... (continue reading...)

IRVINE, CA / ACCESSWIRE / May 20, 2024 / Allied Universal Holdco LLC and Allied Universal Finance Corporation (collectively, "Allied Universal") today announced the early results of the previously announced cash tender offer (the "Tender Offer") to purchase for cash up to $739,000,000 in aggregate consideration (exclusive of accrued and unpaid interest, the "Accrued Interest", and as such aggregate consideration may be increased or decreased by Allied Universal, the... (continue reading...)